Immunomodulation

EBV-EBNA1 constructs an immunosuppressive microenvironment for nasopharyngeal carcinoma by promoting the chemoattraction of Treg cells
Shaofen Huo, Yunfan Luo, Rui Deng, Xiong Liu, Jie Wang, Lu Wang, Bao Zhang, Fan Wang, Juan Lu, Xiangping Li

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001588; DOI: 10.1136/jitc-2020-001588
Synergizing sunitinib and radiofrequency ablation to treat hepatocellular cancer by triggering the antitumor immune response
Xiaoqiang Qi, Ming Yang, Lixin Ma, Madeline Sauer, Diego Avella, Jussuf T Kaifi, Jeffrey Bryan, Kun Cheng, Kevin F Staveley-O’Carroll, Eric T Kimchi, Guangfu Li

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001038; DOI: 10.1136/jitc-2020-001038
Role of myeloid-derived suppressor cells in the promotion and immunotherapy of colitis-associated cancer
Yungang Wang, Yanxia Ding, Yijun Deng, Yu Zheng, Shengjun Wang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000609; DOI: 10.1136/jitc-2020-000609
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
Kim M van Pul, Ronald J C L M Vuylsteke, Monique T A de Beijer, Rieneke van de Ven, M Petrousjka van den Tol, Hein B A C Stockmann, Tanja D de Gruijl

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000761; DOI: 10.1136/jitc-2020-000761
Evolving impact of long-term survival results on metastatic melanoma treatment
Olivier Michielin, Michael B Atkins, Henry B Koon, Reinhard Dummer, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000948; DOI: 10.1136/jitc-2020-000948
Nanoemulsion adjuvantation strategy of tumor-associated antigen therapy rephrases mucosal and immunotherapeutic signatures following intranasal vaccination
Chung-Hsiung Huang, Chiung-Yi Huang, Hui-Min Ho, Ching-Hung Lee, Pang-Ti Lai, Suh-Chin Wu, Shih-Jen Liu, Ming-Hsi Huang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001022; DOI: 10.1136/jitc-2020-001022
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy
David J Pinato, Ahmed Kaseb, Yinghong Wang, Anwaar Saeed, David Szafron, Tomi Jun, Sirish Dharmapuri, Abdul Rafeh Naqash, Mahvish Muzaffar, Musharraf Navaid, Uqba Khan, ChiehJu Lee, Anushi Bulumulle, Bo Yu, Sonal Paul, Petros Fessas, Neil Nimkar, Dominik Bettinger, Hannah Hildebrand, Tiziana Pressiani, Yehia I Abugabal, Nicola Personeni, Yi-Hsiang Huang, Jingky Lozano-Kuehne, Lorenza Rimassa, Celina Ang, Thomas U Marron

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e000726; DOI: 10.1136/jitc-2020-000726
2,5-dimethylcelecoxib improves immune microenvironment of hepatocellular carcinoma by promoting ubiquitination of HBx-induced PD-L1
Zhanfei Chen, Yiyin Chen, Lirong Peng, Xiaoqian Wang, Nanhong Tang

Journal for ImmunoTherapy of Cancer Oct 2020, 8 (2) e001377; DOI: 10.1136/jitc-2020-001377
Bone marrow MSC from pediatric patients with B-ALL highly immunosuppress T-cell responses but do not compromise CD19-CAR T-cell activity
Samanta Romina Zanetti, Paola Alejandra Romecin, Meritxell Vinyoles, Manel Juan, José Luis Fuster, Mireia Cámos, Sergi Querol, Mario Delgado, Pablo Menendez

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001419; DOI: 10.1136/jitc-2020-001419
Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer
Michael Brandon Ware, Bassel F El-Rayes, Gregory B Lesinski

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001100; DOI: 10.1136/jitc-2020-001100

Main menu

Immunomodulation

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunomodulation

Pages